Drug Toxicity Testing
Drug Toxicity Testing is a scientific methodology within preclinical drug development that employs in vitro models, particularly organ-on-chip systems, to assess the adverse effects of pharmaceutical compounds on human physiological functions, thereby differentiating it from efficacy-focused or in silico screening approaches.
752
Publications
41.7K
Citations
3.7K
Authors
1.2K
Institutions
Publications per year
2017–2026
149
752
1–5 of 752
3.7K
5
h-index
5
h-index
In Vitro Admet Laboratories (United States), United States
5 publications · 307 citations
5
h-index
National Center for Toxicological Research, United States
4 publications · 139 citations
4
h-index
4
h-index
1–5 of 3.7K
1.2K
Pfizer (United States)
New York, United States
16 h-index
68 publications
17.2K citations
National Institutes of Health
Bethesda, United States
14 h-index
57 publications
3.1K citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
14 h-index
39 publications
3.6K citations
Harvard University
Cambridge, United States
12 h-index
41 publications
11.3K citations
Joint Research Centre
Ispra, Italy
10 h-index
32 publications
1.1K citations
National Cancer Institute
Bethesda, United States
10 h-index
34 publications
1.9K citations
United States Food and Drug Administration
Silver Spring, United States
10 h-index
50 publications
5.2K citations
National Center for Toxicological Research
Pine Bluff, United States
10 h-index
21 publications
810 citations
1–8 of 1.2K
Repository · 74 publications · 2.9K citations
32
h-index
19 publications · 956 citations
16
h-index
RTP · 17 publications · 754 citations
16
h-index
12 publications · 1.1K citations
12
h-index
11 publications · 432 citations
11
h-index
1–5